140 related articles for article (PubMed ID: 31589917)
1. Acute exposure to leucine modifies behavioral parameters and cholinergic activity in zebrafish.
Wessler LB; Farias HR; Ronsani JF; Candiotto G; Dos Santos PCL; de Oliveira J; Rico EP; Streck EL
Int J Dev Neurosci; 2019 Nov; 78():222-226. PubMed ID: 31589917
[TBL] [Abstract][Full Text] [Related]
2. Exposure to leucine induces oxidative stress in the brain of zebrafish.
de Medeiros BZ; Wessler LB; Duarte MB; Lemos IS; Candiotto G; Canarim RO; Dos Santos PCL; Torres CA; Scaini G; Rico EP; Generoso JS; Streck EL
Metab Brain Dis; 2022 Apr; 37(4):1155-1161. PubMed ID: 35275349
[TBL] [Abstract][Full Text] [Related]
3. Melatonin improves behavioral parameters and oxidative stress in zebrafish submitted to a leucine-induced MSUD protocol.
Duarte MB; Medeiros BZ; da Silva Lemos I; da Silva GL; Alano CG; Dondossola ER; Torres CA; Effting PS; Rico EP; Streck EL
Metab Brain Dis; 2023 Aug; 38(6):2105-2114. PubMed ID: 37099078
[TBL] [Abstract][Full Text] [Related]
4. Memantine Improves Memory and Neurochemical Damage in a Model of Maple Syrup Urine Disease.
Lemos IDS; Torres CA; Alano CG; Matiola RT; de Figueiredo Seldenreich R; Padilha APZ; De Pieri E; Effting PS; Machado-De-Ávila RA; Réus GZ; Leipnitz G; Streck EL
Neurochem Res; 2024 Mar; 49(3):758-770. PubMed ID: 38104040
[TBL] [Abstract][Full Text] [Related]
5. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
6. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
[TBL] [Abstract][Full Text] [Related]
7. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
8. Exposure to leucine alters glutamate levels and leads to memory and social impairment in zebrafish.
da Silva Lemos I; Wessler LB; Duarte MB; da Silva GL; Bernardo HT; Candiotto G; Torres CA; Petronilho F; Rico EP; Streck EL
Metab Brain Dis; 2022 Dec; 37(8):2925-2935. PubMed ID: 36040712
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of branched-chain amino acids in maple syrup urine disease.
Schadewaldt P; Wendel U
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant administration prevents memory impairment in an animal model of maple syrup urine disease.
Scaini G; Teodorak BP; Jeremias IC; Morais MO; Mina F; Dominguini D; Pescador B; Comim CM; Schuck PF; Ferreira GC; Quevedo J; Streck EL
Behav Brain Res; 2012 May; 231(1):92-6. PubMed ID: 22433584
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
12. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
Xu J; Jakher Y; Ahrens-Nicklas RC
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
[TBL] [Abstract][Full Text] [Related]
13. Melatonin ameliorates oxidative stress and DNA damage of rats subjected to a chemically induced chronic model of Maple Syrup Urine Disease.
Wessler LB; Ise K; Lemos IC; Rezende VL; Duarte MB; Damiani AP; de Oliveira J; de Andrade VM; Streck EL
Metab Brain Dis; 2020 Aug; 35(6):905-914. PubMed ID: 32297169
[TBL] [Abstract][Full Text] [Related]
14. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
15. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats.
Wessler LB; de Miranda Ramos V; Bittencourt Pasquali MA; Fonseca Moreira JC; de Oliveira J; Scaini G; Streck EL
Int J Dev Neurosci; 2019 Nov; 78():210-214. PubMed ID: 31330240
[TBL] [Abstract][Full Text] [Related]
16. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
[TBL] [Abstract][Full Text] [Related]
17. Maple syrup urine disease decompensation misdiagnosed as a psychotic event.
Higashimoto T; Whitehead MT; MacLeod E; Starin D; Regier DS
Mol Genet Metab Rep; 2022 Sep; 32():100886. PubMed ID: 35756860
[TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P
Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286
[TBL] [Abstract][Full Text] [Related]
19. Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks.
Vasques Vde C; Brinco F; Wajner M
J Neurol Sci; 2005 May; 232(1-2):11-21. PubMed ID: 15850577
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
Mescka CP; de Moura Coelho D; Sitta A; Catarino F; Donida B; Rosa AP; Gonzalez EA; Pinheiro CV; Poletto F; Baldo G; Dutra-Filho CS; Vargas CR
Metab Brain Dis; 2021 Jun; 36(5):1015-1027. PubMed ID: 33620579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
